Buffalo BioSciences partner Eric Cornavaca successfully coaches the NanoAxis team to First Place Prize of $25,000 in the 2008 Panasci Technology Entrepreneurship & Business Plan Competition presented by the University at Buffalo's Center for Entrepreneurial Leadership. Read More...
Buffalo BioSciences partner Anthony Johnson comments on how the region's ability to attract scientific talent impacts technology transfer and commercialization in the Buffalo News Prospectus 2008 article by Fred Williams titled "Nascent biotech sector is beginning to bloom" (Pages 52 - 53).
Buffalo BioSciences partner Anthony Johnson co-authors paper with Kevin Stevens from Blue Mars Software outlining how the successful submission of a 510(k) rests heavily on the device manufacturer's ability to demonstrate their software will perform as required. The article titled "Lower Cost and Faster Product Approval Through Proper Software Design Controls" can be found in the December 2007 issue of BIOTECHNOLOGY HEALTHCARE.
Buffalo BioSciences partner Anthony Johnson discusses technology transfer partnerships and licensing strategies for the University of Massachusetts in a Worcester Business Journal article by Cory Hopkins titled "Biotech Buzz: Let's Make A Deal."
Buffalo BioSciences and Empire Genomics are featured in recent Genetic Engineering & Biotechnology News article highlighting Buffalo's ongoing investments and inititives to become a hot spot for the life science industry. The story titled "Benefits Point Biotech Firms to Buffalo" was written by Vicki Brower.
Buffalo BioSciences and Jaeckle Fleischmann & Mugel, LLP announce strategic alliance to help life science companies, scientists, technology transfer offices and independent researchers commercialize innovative technologies. The partnership combines Buffalo BioSciences' business development and management capabilities with Jaeckle's Translational Patenting services. More about the alliance is reported in the recently published Buffalo Law Journal article by Brenda Alesii titled "Law firm, bioscience company partner up."
Buffalo BioSciences Partner Eric Cornavaca appointed to newly created Industrial Advisory Board at the University at Buffalo Center for Advanced Biomedical and Bioengineering Technology (UB CAT). One of fifteen Centers for Advanced Technology located across New York State, the UB CAT supports university-industry collaboration and focuses on biomedical and bioengineering research that can lead to development of useful products with commercialization potential.
Buffalo News business reporter Fred Williams examines how Empire Genomics uses genetic code to help doctors see and treat health problems in a recent article titled "Area firm plans to market genetic tests for illnesses."
Empire Genomics' innovative technology and expansion plans are showcased in recent Business First of Buffalo article by Annemarie Franczyk titled "Test developed for chromosome defect." Empire Genomics is one of Buffalo BioSciences' early-stage portfolio companies.
Press conference on July 12, 2007 @ 11:00am at the NYS Center of Excellence in Bioinformatics & Life Sciences to announce the formation and official launch of Buffalo's newest life sciences company: Empire Genomics LLC. The company develops innovative genomic products and services that enable personalized medicine to become a reality.
RED HERRING journalist Amy Coombs writes about new CATALYST SERVICES in "Bringing Biotech to Little Burgs." Explains how new economic development offering helps smaller cities grab a piece of the biotech pie.
Buffalo BioSciences Announces New Economic Development Training Service; Pins Key Expert to Lead Offering. CATALYST SERVICES will help Economic Development Organizations target technology sector growth opportunities.
Buffalo BioSciences heads to Seventh Annual SmartStart Venture Forum in Albany, NY. This unique event displays the very best early-stage companies from throughout the entire state of New York.
Buffalo News Columnist Donn Esmonde profiles MEDCOTEK's CEO Fred Zeigler and other local life science companies in commentary article titled "The trickle of good jobs has begun."
Buffalo BioSciences selected for Life Sciences Achievement Award at infoTech Niagara's 7th Annual BETA Awards. Given to companies that have recently brought new technology, practices or facilities to market, other finalists selected within this award category include: The New York State Center of Excellence in Bioinformatics & Life Sciences, Oncology Research Therapeutics, Central Radiopharmaceutical Services and PersonaDX.
Buffalo News business reporter Fred Williams explains how MEDCOTEK is relocating to the Buffalo Niagara Medical Campus in a recent article titled "New X-ray firm moving here from N.C."
Buffalo BioSciences attracts MEDCOTEK to NYS Center of Excellence in Bioinformatics & Life Sciences as reported in Business First of Buffalo article by Annemarie Franczyk titled "Med-tech firm makes N.C.-to-Buffalo move."
Partnership between Buffalo BioSciences and E-Capital Financing drives the strategic growth of MEDCOTEK into the global medical imaging and archiving markets. The North Carolina medical-technology company will relocate to the New York State Center of Excellence in Bioinformatics & Life Sciences. more...
Buffalo BioSciences Partner Eric Cornavaca participates as guest lecturer for the Fundamentals of the Bioscience Industry Program at Stony Brook University. Conducted online via teleconference, Eric's presenation injected real life experiences to the identification and utilization of "Strategic Supplier Relationships."
Bruce Holm, Ph.D., Executive Director of the New York State Center of Excellence in Bioinformatics & Life Sciences explains how Buffalo BioSciences supports commercialization efforts in recent Buffalo News article by Fred Williams titled "UB Bolsters its Supercomputer."
Buffalo BioSciences Partner Anthony Johnson contributes to Business First of Buffalo article by Annemarie Franczyk titled "Biotech firm has high hopes for SmartPill."
Buffalo BioSciences and ECapital-Financing profiled in Buffalo News article "WORKING CAPITAL: Joint Venture Formed to Fund Life Science Start-Ups" by Fred Williams, News Business Reporter.
Buffalo BioSciences featured in Business First of Buffalo article by Annemarie Franczyk titled "Bioscience Sector Subject of Partnership."
Buffalo BioSciences & ECapital-Financing Announce a Joint Venture to Focus on Bioscience Companies. more...
Buffalo BioSciences and regional life sciences cluster showcased on Page 49 of the Buffalo News Prospectus - The Year's Business Forecast: "Fledgling Biotechnology Sector Gains Momentum."
Buffalo BioSciences Partner Eric Cornavaca named as judge for infoTech Niagara's upcoming 2007 Buffalo/Niagara Emerging Technology Awards.
Empire Genomics, a Buffalo BioSciences portfolio company, has signed key agreement with Agilent Technologies Inc. to become Certified Microarray Service Provider. more...
Buffalo BioSciences Partner Eric Cornavaca is elected to serve on Niagara University’s Business Advisory Board with special focus on Life Science commercialization.
Buffalo BioSciences Partners partcipate as panel members in 6th Annual WNY Technology Forum. Eric Cornavaca contributed to the session "From Idea to Launch: Keys to Successful Product Development" while Anthony Johnson moderated "Cyberinfrastructure Impacts on Commercialization Work Flows."
Empire Genomics, a Buffalo BioSciences portfolio company, and Population Diagnostics Create Expansive Relationship for Large Scale Molecular Diagnostics & Personalized Medicine Development Program. more...
Buffalo BioSciences signs strategic agreement to become commercialization partner for the University at Buffalo.
NutriCyte Corporation names Buffalo BioSciences Strategic Advisor Vic Nole as its new CEO. more...
Buffalo BioSciences signs partner relationship agreement to become preferred commercialization resource for the recently completed NYS Center of Excellence in Bioinformatics & Life Sciences. more...